In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019

Infective endocarditis (IE) is a rare but serious complication following a Solid Organ Transplant (SOT). Due to the lack of sufficient studies, we aimed to compare in-hospital mortality and length of stay (LOS) of patients primarily admitted for IE (index or principal hospitalization) with history o...

Full description

Bibliographic Details
Main Authors: Nischit Baral, Annabelle Santos Volgman, Tripti Gupta, Arvind Kunadi, Mahin R. Khan, Soumya Kambalapalli, Hameem U. Changezi, Melissa Tracy
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022009434
_version_ 1818242167151263744
author Nischit Baral
Annabelle Santos Volgman
Tripti Gupta
Arvind Kunadi
Mahin R. Khan
Soumya Kambalapalli
Hameem U. Changezi
Melissa Tracy
author_facet Nischit Baral
Annabelle Santos Volgman
Tripti Gupta
Arvind Kunadi
Mahin R. Khan
Soumya Kambalapalli
Hameem U. Changezi
Melissa Tracy
author_sort Nischit Baral
collection DOAJ
description Infective endocarditis (IE) is a rare but serious complication following a Solid Organ Transplant (SOT). Due to the lack of sufficient studies, we aimed to compare in-hospital mortality and length of stay (LOS) of patients primarily admitted for IE (index or principal hospitalization) with history of SOT, including the subgroup of heart or lung transplant (HLT), to those without a history of SOT (non-SOT) or HLT (non-HLT). We used the 2016–2019 National Inpatient Sample, the largest all-payer inpatient hospital data from Healthcare Cost and Utilization Project (HCUP), including patients 18 years or older with IE, as a principal diagnosis for hospitalization. From 2016 to 2019, there were 56,330 principal or index hospitalizations for IE. Among them, 0.6 % (n = 327) were SOT recipients, 0.1% (n = 68) were HLT recipients, and 41.4% were females. The mean age was 51.9 ± 19.2 years. Compared to non-SOT controls, SOT recipients were older (mean age 59.3 vs. 51.8 years; P = 0.002) and had higher Charlson-comorbidity-index (CCI) of 3 or more (87.7% vs. 33.2%; p < 0.001). SOT status was not statistically significant for a higher or lower odds of in-hospital mortality (adjusted odds ratio (aOR) 0.7; 95% confidence interval (CI): 0.2, 2.4; p = 0.60) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.4, 0.1; p = 0.23) among index IE hospitalizations after controlling for age, sex, race, hospital-region, hospital-teaching status, income, insurance status, and CCI. HLT status was also not associated with higher or lower odds of in-hospital mortality (aOR 1.4; 95% CI: 0.2, 13.1; p = 0.77) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.3, 0.5; p = 0.59). From 2016 to 2019, the rate of index IE hospitalization trends from 37.8 to 41.4 per 100,000 overall hospitalizations (p = 0.001). We found the rate of index IE hospitalizations increasing with time. Among index IE hospitalizations, SOT, including a subgroup of HLT recipients, have similar in-hospital mortality and LOS compared to non-SOT or non-HLT groups. We need a larger sample size to comment on outcomes of IE hospitalizations with the HLT subgroup.
first_indexed 2024-12-12T13:40:55Z
format Article
id doaj.art-174a3be2d61843a6a7c09eb1f0aa18ed
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-12-12T13:40:55Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-174a3be2d61843a6a7c09eb1f0aa18ed2022-12-22T00:22:48ZengElsevierHeliyon2405-84402022-06-0186e09655In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019Nischit Baral0Annabelle Santos Volgman1Tripti Gupta2Arvind Kunadi3Mahin R. Khan4Soumya Kambalapalli5Hameem U. Changezi6Melissa Tracy7Department of Internal Medicine, McLaren Flint/Michigan State University College of Human Medicine, Flint, Michigan, USA; Corresponding author.Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, Chicago, IL, USADepartment of Internal Medicine, Division of Cardiology, Ochsner Medical Center, New Orleans, LA, USADepartment of Internal Medicine, McLaren Flint/Michigan State University College of Human Medicine, Flint, Michigan, USADepartment of Internal Medicine, McLaren Flint/Michigan State University College of Human Medicine, Flint, Michigan, USADepartment of Internal Medicine, McLaren Flint/Michigan State University College of Human Medicine, Flint, Michigan, USADepartment of Internal Medicine, McLaren Flint/Michigan State University College of Human Medicine, Flint, Michigan, USADepartment of Internal Medicine, Division of Cardiology, Rush University Medical Center, Chicago, IL, USAInfective endocarditis (IE) is a rare but serious complication following a Solid Organ Transplant (SOT). Due to the lack of sufficient studies, we aimed to compare in-hospital mortality and length of stay (LOS) of patients primarily admitted for IE (index or principal hospitalization) with history of SOT, including the subgroup of heart or lung transplant (HLT), to those without a history of SOT (non-SOT) or HLT (non-HLT). We used the 2016–2019 National Inpatient Sample, the largest all-payer inpatient hospital data from Healthcare Cost and Utilization Project (HCUP), including patients 18 years or older with IE, as a principal diagnosis for hospitalization. From 2016 to 2019, there were 56,330 principal or index hospitalizations for IE. Among them, 0.6 % (n = 327) were SOT recipients, 0.1% (n = 68) were HLT recipients, and 41.4% were females. The mean age was 51.9 ± 19.2 years. Compared to non-SOT controls, SOT recipients were older (mean age 59.3 vs. 51.8 years; P = 0.002) and had higher Charlson-comorbidity-index (CCI) of 3 or more (87.7% vs. 33.2%; p < 0.001). SOT status was not statistically significant for a higher or lower odds of in-hospital mortality (adjusted odds ratio (aOR) 0.7; 95% confidence interval (CI): 0.2, 2.4; p = 0.60) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.4, 0.1; p = 0.23) among index IE hospitalizations after controlling for age, sex, race, hospital-region, hospital-teaching status, income, insurance status, and CCI. HLT status was also not associated with higher or lower odds of in-hospital mortality (aOR 1.4; 95% CI: 0.2, 13.1; p = 0.77) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.3, 0.5; p = 0.59). From 2016 to 2019, the rate of index IE hospitalization trends from 37.8 to 41.4 per 100,000 overall hospitalizations (p = 0.001). We found the rate of index IE hospitalizations increasing with time. Among index IE hospitalizations, SOT, including a subgroup of HLT recipients, have similar in-hospital mortality and LOS compared to non-SOT or non-HLT groups. We need a larger sample size to comment on outcomes of IE hospitalizations with the HLT subgroup.http://www.sciencedirect.com/science/article/pii/S2405844022009434Infective endocarditisSolid organ transplantHeart or lung transplantIn-hospital mortality
spellingShingle Nischit Baral
Annabelle Santos Volgman
Tripti Gupta
Arvind Kunadi
Mahin R. Khan
Soumya Kambalapalli
Hameem U. Changezi
Melissa Tracy
In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
Heliyon
Infective endocarditis
Solid organ transplant
Heart or lung transplant
In-hospital mortality
title In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_full In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_fullStr In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_full_unstemmed In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_short In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_sort in hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant a study from national inpatient sample 2016 2019
topic Infective endocarditis
Solid organ transplant
Heart or lung transplant
In-hospital mortality
url http://www.sciencedirect.com/science/article/pii/S2405844022009434
work_keys_str_mv AT nischitbaral inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT annabellesantosvolgman inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT triptigupta inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT arvindkunadi inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT mahinrkhan inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT soumyakambalapalli inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT hameemuchangezi inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT melissatracy inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019